Matches in Wikidata for { <http://www.wikidata.org/entity/Q91870163> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q91870163 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91870163 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91870163 description "scientific article published on 13 April 2020" @default.
- Q91870163 description "wetenschappelijk artikel" @default.
- Q91870163 description "наукова стаття, опублікована 13 квітня 2020" @default.
- Q91870163 name "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 name "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 type Item @default.
- Q91870163 label "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 label "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 prefLabel "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 prefLabel "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 P1433 Q91870163-17BF6DBB-62A8-46E1-9D9A-199D9EB95836 @default.
- Q91870163 P1476 Q91870163-C8667451-9259-4C2E-B431-550E306FDAF8 @default.
- Q91870163 P2093 Q91870163-127861C3-5BEC-47F9-B4F5-142207403BF5 @default.
- Q91870163 P2093 Q91870163-1E09051F-FC9E-4F09-9A03-ACBFA659A14D @default.
- Q91870163 P2093 Q91870163-32A0169C-D555-413D-978D-E312CECF0361 @default.
- Q91870163 P2093 Q91870163-454CFD95-1580-4115-A0DE-F2F5D7574FD8 @default.
- Q91870163 P2093 Q91870163-5CC04A67-A46C-4A06-8817-C0C425A0D1FE @default.
- Q91870163 P2093 Q91870163-74238AEE-D330-496E-8406-ABC6E577DD0E @default.
- Q91870163 P2093 Q91870163-C174689F-CDF5-4A0D-A190-09723B23DEF3 @default.
- Q91870163 P2093 Q91870163-C4974A1A-5CEE-4E4E-85B7-08786FE479A5 @default.
- Q91870163 P2093 Q91870163-C6FCEE34-704E-4409-80EB-5B90EEC832D0 @default.
- Q91870163 P2093 Q91870163-D2806F1B-ADC4-4781-B10B-A2C26AE14227 @default.
- Q91870163 P2093 Q91870163-DCB8493B-9B36-46F3-B848-861C4760E754 @default.
- Q91870163 P2093 Q91870163-FC0D0F41-3210-43D7-9C1A-231DE6F51A63 @default.
- Q91870163 P31 Q91870163-58F20CA7-2771-4B05-BE71-05B05581F5FC @default.
- Q91870163 P356 Q91870163-9FCE2351-FCE4-4F25-AD6D-A69F677AD710 @default.
- Q91870163 P50 Q91870163-17C1426B-0EC5-4F06-BAE8-CB522EDAEC83 @default.
- Q91870163 P577 Q91870163-09C1B0AC-569E-4E6B-88BD-80F350127408 @default.
- Q91870163 P698 Q91870163-552EB2F8-9505-4FF8-A75B-36234EB6D8B8 @default.
- Q91870163 P356 ACSINFECDIS.9B00505 @default.
- Q91870163 P698 32283915 @default.
- Q91870163 P1433 Q24067932 @default.
- Q91870163 P1476 "Preclinical gold complexes as oral drug candidates to treat leishmaniasis are potent trypanothione reductase inhibitors" @default.
- Q91870163 P2093 "Adriana Garcia" @default.
- Q91870163 P2093 "André Luis Branco de Barros" @default.
- Q91870163 P2093 "Frédéric Frézard" @default.
- Q91870163 P2093 "Heveline Silva" @default.
- Q91870163 P2093 "Hélio F Dos Santos" @default.
- Q91870163 P2093 "José D Corrêa-Junior" @default.
- Q91870163 P2093 "Luiza Tunes" @default.
- Q91870163 P2093 "Mauro V De Almeida" @default.
- Q91870163 P2093 "Nilmar Moretti" @default.
- Q91870163 P2093 "Roberta Morato" @default.
- Q91870163 P2093 "Rubens L Monte-Neto" @default.
- Q91870163 P2093 "Vinícius Schmitz" @default.
- Q91870163 P31 Q13442814 @default.
- Q91870163 P356 "10.1021/ACSINFECDIS.9B00505" @default.
- Q91870163 P50 Q56839643 @default.
- Q91870163 P577 "2020-04-13T00:00:00Z" @default.
- Q91870163 P698 "32283915" @default.